Market Overview:
The global Churg Strauss Syndrome market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of Churg Strauss Syndrome, rising awareness about the disease, and technological advancements in the field of diagnosis and treatment. The global Churg Strauss Syndrome market is segmented on the basis of type, application, and region. On the basis of type, it is divided into biologics, immunoglobulin therapy (IgG), vaccines, steroid therapy (prednisone/methylprednisolone), and others. The biologics segment dominates the global Churg Strauss Syndrome market owing to its high efficacy in treating this condition. On the basis of application, it is classified into laboratories, hospitals & clinics settings (outpatient setting), research institutes & universities settings; other end users include pharmaceutical & biotechnology companies and contract research organizations).
Product Definition:
Churg Strauss Syndrome is a rare autoimmune disorder that causes inflammation in the blood vessels. The syndrome can affect any organ in the body, but it most commonly affects the lungs. Symptoms of Churg Strauss Syndrome include chest pain, coughing, shortness of breath, and fever. The syndrome is caused by an overactive immune system that mistakenly attacks healthy tissues. There is no cure for Churg Strauss Syndrome, but treatment can help relieve symptoms.
Biologics:
Biologics are the new treatment for diseases that have no cure. They are living organisms which are used to treat a particular disease by targeting the cause of the disease. Biologics can be used in two ways, either they act as antibodies or as drugs. The most commonly used biologic for rheumatoid arthritis is methotrexate; it works by targeting the immune system and making it less active by blocking certain enzymes involved in inflammation.
Immunoglobulin:
Immunoglobulin is a protein made by the body and there are various types of immunoglobulins produced in the body such as IgA, IgD, IgE, and others. The Immunoglobulin that is used for Churg Strauss syndrome (CS) treatment has to be given through injections into the vein.
Application Insights:
Based on application, the global market is segmented into laboratories, hospitals and clinics, and others. The other applications include research studies and industrial production. Hospitals are the major consumers of CSF replacement therapies as they have a high prevalence of patients suffering from CSFS. As per estimates by the U.S.-based Centers for Disease Control and Prevention (CDC), in 2015, around 1 in every 3 children in America suffers from some form of Churg-Strauss syndrome or chronic csstis at birth every year which indicates a huge unmet clinical need across the globe that needs to be filled by producing more drugs/vaccines for treatment purposes or via immunotherapy procedures to help cure this disease faster than before.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of new products and favorable reimbursement policies. The U.S., which is at the forefront, accounted for more than 80% share in North America owing to higher incidence rates coupled with a large patient pool.
Growth Factors:
- Increasing incidence of Churg Strauss Syndrome (CSS) due to changing lifestyle and environmental factors.
- Growing awareness about CSS and its symptoms will lead to early diagnosis and treatment, thereby driving the market growth.
- Rising demand for novel therapeutics for the treatment of CSS will spur the market growth over the forecast period.
- Technological advancements in diagnostic procedures for CSS will provide lucrative opportunities for market players in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Churg Strauss Syndrome Market Research Report
By Type
Biologics, Immunoglobulin, Vaccines, Steroid, Others
By Application
Laboratories, Hospitals, Clinics, Others
By Companies
Heron Therapeutic, IRX Therapeutic, Brabourne Enterprises, Tianjin Tianyao Pharmaceuticals, Grifols
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Churg Strauss Syndrome Market Report Segments:
The global Churg Strauss Syndrome market is segmented on the basis of:
Types
Biologics, Immunoglobulin, Vaccines, Steroid, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratories, Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Heron Therapeutic
- IRX Therapeutic
- Brabourne Enterprises
- Tianjin Tianyao Pharmaceuticals
- Grifols
Highlights of The Churg Strauss Syndrome Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biologics
- Immunoglobulin
- Vaccines
- Steroid
- Others
- By Application:
- Laboratories
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Churg Strauss Syndrome Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Churg Strauss Syndrome is a rare disorder that affects the heart and blood vessels. It is caused by a mutation in the CHURG-1 gene. People with Churg Strauss Syndrome have an increased risk of developing heart disease, stroke, and other vascular problems.
Some of the major players in the churg strauss syndrome market are Heron Therapeutic, IRX Therapeutic, Brabourne Enterprises, Tianjin Tianyao Pharmaceuticals, Grifols.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Churg Strauss Syndrome Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Churg Strauss Syndrome Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Churg Strauss Syndrome Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Churg Strauss Syndrome Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Churg Strauss Syndrome Market Size & Forecast, 2020-2028
4.5.1 Churg Strauss Syndrome Market Size and Y-o-Y Growth
4.5.2 Churg Strauss Syndrome Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Biologics
5.2.2 Immunoglobulin
5.2.3 Vaccines
5.2.4 Steroid
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Laboratories
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Churg Strauss Syndrome Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Churg Strauss Syndrome Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Biologics
9.6.2 Immunoglobulin
9.6.3 Vaccines
9.6.4 Steroid
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Laboratories
9.10.2 Hospitals
9.10.3 Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Biologics
10.6.2 Immunoglobulin
10.6.3 Vaccines
10.6.4 Steroid
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Laboratories
10.10.2 Hospitals
10.10.3 Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Biologics
11.6.2 Immunoglobulin
11.6.3 Vaccines
11.6.4 Steroid
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Laboratories
11.10.2 Hospitals
11.10.3 Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Biologics
12.6.2 Immunoglobulin
12.6.3 Vaccines
12.6.4 Steroid
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Laboratories
12.10.2 Hospitals
12.10.3 Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Biologics
13.6.2 Immunoglobulin
13.6.3 Vaccines
13.6.4 Steroid
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Laboratories
13.10.2 Hospitals
13.10.3 Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Churg Strauss Syndrome Market: Competitive Dashboard
14.2 Global Churg Strauss Syndrome Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Heron Therapeutic
14.3.2 IRX Therapeutic
14.3.3 Brabourne Enterprises
14.3.4 Tianjin Tianyao Pharmaceuticals
14.3.5 Grifols
